The York Cancer Center strives to bring the most current cancer therapies
available to our community, with respect to treatment, symptom management, and
prevention. We continue to collaborate in a large number of National Cancer
Institute and industry-sanctioned cooperative group trials. These collaborations
have allowed us the opportunity to help bring some cancer treatments to our
community that would normally be available only at larger centers or
universities.
Our research team continually works to provide the community with a variety of
treatment trials. The research team is a dedicated group of professionals who
work in conjunction with physicians, nurses and patients to facilitate
enrollment in clinical trials, provide protocol therapy and detail collection of
research data, which is then submitted to the statistical centers.
The following is a list of the cancer treatment clinical trials that are
currently available to our patients in the community.
To learn more about treatment studies, talk to your physician or call us at
(717) 741-8100 or (877) 441-7957.
RTOG 0627 - Suspended to Enrollment August 10, 2010BrainPhase II Trial of Dasatinib in Patients with Recurrent Glioblastoma Multiforme
Record Created: 2007-04-23 15:39:20
|
RTOG 0825 BrainPhase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma
Record Created: 2009-11-24 13:37:24
|
ACOSOG Z1071BreastA Phase II Study Evaluating the Role of Sentinel Lymph Node Surgery and Axillary Node Dissection Following Preoperative Chemotherapy in Women with Node Positive Breast Cancer (T1-4, N1-2, M0) at Initial Diagnosis
Record Created: 2009-08-17 10:22:18
|
ECOG E5103 BreastA Double- Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Record Created: 2008-07-07 10:18:58
|
J0805 (JH PBIC)BreastA Phase I/II Partial Breast Irradiation Concurrent with Chemotherapy
Record Created: 2008-10-15 11:11:53
|
NSABP B-43BreastA Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy
Record Created: 2009-01-08 12:29:54
|
NSABP B-44-I - BETH Trial - Projected to close September 11, 2010BreastA Multicenter Phase III Randomized Trial of Adjuvant Therapy for Patients with Her2-Positive Node-Positive or High Risk Node-Negative Breast Cancer Comparing Chemotherapy Plus Trastuzumab with Chemotherapy Plus Trastuzumab Plus Bevacizumab
Record Created: 2008-06-25 10:39:12
|
York Cancer Center Patient RegistryBreastYork Cancer Center Patient Registry: A Study to Compile Information on the Efficacy of High Dose Rate (HDR) Brachytherapy in Providing Radiation Therapy to Breast Cancer Patients
Record Created: 2006-04-03 17:04:28
|
ACOSOG Z4051 EsophagealA Phase II Study of Neoadjuvant Therapy with Cisplatin, Docetaxel, Panitumumab Plus Radiation Therapy Followed By Surgery in Patients with Locally Advanced Adenocarcinoma of the Distal Esophagus
Record Created: 2009-04-14 14:15:29
|
RTOG 0436EsophagealA Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery
Record Created: 2008-09-04 13:54:49
|
CALGB C80405 GIA PHASE III TRIAL OF IRINOTECAN/5-FU/LEUCOVORIN OR OXALIPLATIN/5-FU/LEUCOVORIN WITH BEVACIZUMAB, OR CETUXIMAB (C225), OR WITH THE COMBINATION OF BEVACIZUMAB AND CETUXIMAB FOR PATIENTS WITH UNTREATED METASTATIC ADENOCARCINOMA OF THE COLON OR RECTUM
Record Created: 2008-02-18 12:12:56
|
ECOG E5202GIA Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin and Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers
Record Created: 2009-05-11 11:30:44
|
NSABP P-5GIStatin Polyp Prevention Trial in Patients with Resected Colon Cancer
Record Created: 2010-05-11 10:56:09
|
RTOG 0848GIA Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma
Record Created: 2010-06-02 13:25:20
|
RTOG 0920Head & NeckA Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally Advanced Resected Head ad Neck Cancer
Record Created: 2010-02-02 14:58:20
|
CALGB 140503LungA Phase III Randomized Trial of Lobectomy versus Sublobar Resection for Small (< or = 2 cm) Peripheral NSCLC
Record Created: 2008-02-01 13:37:57
|
CALGB C36010/RTOG 0538LungPhase III Comparison of Thoracic Radiotherapy Regimens in Patients with Limited Small Cell Lung Cancer also Receiving Cisplatin and Etoposide
Record Created: 2008-04-23 14:13:40
|
ECOG E1505LungA Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients with Completely Resected Stage IB (>4cm) – IIIA Non-Small Cell Lung Cancer (NSCLC)
Record Created: 2007-08-20 12:23:59
|
ECOG E1508 LungA Randomized Phase II Study of Cisplatin and Etoposide In Combination with Either Hedgehog Inhibitor GDC-0449 or IGF-1R MOAB IMC-A12 for Patients with Extensive Stage Small Cell Lung Cancer
Record Created: 2009-10-15 15:44:58
|
RTOG 0937LungRandomized Phase II Study Comparing Prophylactic Cranial Irradiation Alone to Prophylactic Cranial Irradiation and Consolidative Extra-Cranial Irradiation for Extensive Disease Small Cell Lung Cancer (ED-SCLC)
Record Created: 2010-06-17 09:22:22
|
ECOG E1697MelanomaPhase III Randomized Study of Four Weeks High Dose IFN-α2b in Stage T2b No, T3a-b, T4a-b No, and T1-4, N1a, 2a, 3 (microscopic) Melanoma
Record Created: 2008-06-25 10:40:29
|
ECOG E1A06Multiple MyelomaAn Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed Myeloma Patients Who Are Not Candidates for High-Dose Therapy
Record Created: 2010-06-02 13:29:22
|
ECOG E3805ProstateCHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer
Record Created: 2006-10-30 16:00:27
|
RTOG 0534ProstateA Randomized Phase III Trial of Short Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed Only Radiotherapy (SPORT) in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
Record Created: 2008-03-27 15:04:59
|
RTOG 0815ProstateA Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer
Record Created: 2009-10-09 11:57:57
|
ECOG E2805 - Closing September 1, 2010RenalA Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma
Record Created: 2007-03-01 10:23:13
|
CALGB 170601Symptom ManagementA Phase III Double Blind Trial of Oral Duloxetine for Treatment of Pain Associated with Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Record Created: 2010-06-17 09:21:07
|
RTOG 0517Symptom ManagementRandomized Phase III Trial to Evaluate Radiopharmaceuticals and Zoledronic Acid in the Palliation of Osteoblastic Metastases from Lung, Breast, and Prostate Cancer
Record Created: 2007-04-23 15:36:58
|
RTOG 0841 Temporarily SuspendedSymptom ManagementEfficiency of Screening for Depression in Cancer Patients Receiving Radiotherapy
Record Created: 2009-08-18 16:17:24
|
